Sperm DNA Damage and Semen Quality Impairment After Treatment With Selective Serotonin Reuptake Inhibitors Detected Using Semen Analysis and Sperm Chromatin Structure Assay

Journal of Urology

Volumn 180, Issue 5, 2008, Pages 2124-2128

  Safarinejad, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

depression; DNA damage; serotonin uptake inhibitors; spermatozoa; testis

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SINGLE STRANDED DNA;

ADULT; ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DEMOGRAPHY; DENATURATION; DEPRESSION; DNA DAMAGE; DNA FRAGMENTATION; EJACULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MORPHOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEMEN ANALYSIS; SPERMATOZOON MOTILITY; TREATMENT DURATION;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OLIGOSPERMIA; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEMEN; SEROTONIN UPTAKE INHIBITORS; SPERM COUNT; SPERM MOTILITY; STATISTICS, NONPARAMETRIC;

EID: 53249097325     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.07.034     Document Type: Article

References (20)

1. Grunebaum M.F., Ellis S.P., Li S., Oquendo M.A., and Mann J.J. Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry 65 (2004) 1456
2. Hughes P., and Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 47 (1995) 133
3. Evenson D.P., Jost L.K., Zinamen M.J., Clegg E., Purvis K., de Angelis P., et al. Utility of the sperm chromatin structure assay (SCSA) as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod 14 (1999) 1039
4. Damberg M., Ekblom J., and Oreland L. Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2. Life Sci 68 (2000) 669
5. Tanrikut C., and Schlegel P.N. Antidepressant-associated changes in semen parameters. Urology 69 185. (2007) e5
6. Evenson D.P., Darzynkiewicz Z., and Melamed M.R. Relation of mammalian sperm chromatin heterogeneity to fertility. Science 210 (1980) 1131
7. Rignell-Hydbom A., Rylander L., Giwercman A., Jönsson B.A., Lindh C., Eleuteri P., et al. Exposure to PCBs and p,p'-DDE and human sperm chromatin integrity. Environ Health Perspect 113 (2005) 175
8. Evenson D.P., Jost L.K., Baer R.K., Turner T., and Schrader S. Individuality of DNA denaturation patterns in human sperm as measured by the sperm chromatin structure assay. Reprod Toxicol 5 (1991) 115
9. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Psychol 6 (1967) 278
10. Levin R.M., Amsterdam J.D., Winokur A., and Wein A.J. Effects of psychotropic drugs on human sperm motility. Fertil Steril 36 (1981) 503
11. Maier U., and Koinig G. Andrological findings in young patients under long-term antidepressive therapy with clomipramine. Psychopharmacology (Berl) 116 (1994) 357
12. Chohan K.R., Griffin J.T., Lafromboise M., De Jonge C.J., and Carrell D.T. Comparison of chromatin assays for DNA fragmentation evaluation in human sperm. J Androl 27 (2006) 53
13. Sendowski K., and Rajewsky M.F. DNA sequence dependence of guanine-O6 alkylation by the N-nitroso carcinogens N-methyl- and N-ethyl-N-nitrosourea. Mutat Res 250 (1991) 153
14. Rodriguez H., Drouin R., Holmquist G.P., O'Connor T.R., Boiteux S., Laval J., et al. Mapping of copper/hydrogen peroxide-induced DNA damage at nucleotide resolution in human genomic DNA by ligation-mediated polymerase chain reaction. J Biol Chem 270 (1995) 17633
15. Nudell D., Castillo M., Turek P.J., and Pera R.R. Increased frequency of mutations in DNA from infertile men with meiotic arrest. Hum Reprod 15 (2000) 1289
16. Hadi N., Singh S., Ahmad A., and Zaidi R. Strand scission in DNA induced by 5-hydroxytryptamine (serotonin) in the presence of copper ions. Neurosci Lett 308 (2001) 83
17. Khan I.A., and Thomas P. Immunocytochemical localization of serotonin and gonadotropin-releasing hormone in the brain and pituitary gland of the Atlantic croaker Micropogonias undulatus. Gen Comp Endocrinol 91 (1993) 167
18. Tanaka E., Baba N., Toshida K., and Suzuki K. Evidence for 5HT2 receptor involvement in the stimulation of preovulatory LH and prolactin release and ovulation in normal cycling rats. Life Sci 52 (1993) 669
19. Schenker J.G., Meirow D., and Schenker E. Stress and human reproduction. Eur J Obstet Gynecol Reprod Biol 45 (1992) 1
20. Meltzer H., Bastani B., Jayathilake K., and Maes M. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 17 (1997) 1